Respi Flashcards
Chronic disease characterized by inflamed hyperresponsive airways.
A. COPD
B. Asthma
C. Allergicrhinitis
D. Bronchitis
E. Emphysema
B
Condition characterized by itchy, watery eyes, runny nose and non-productive cough.
A. COPD
B. Asthma
C. Allergic rhinitis
D. Bronchitis
E. Emphysema
C
Which of the following respiratory conditions may be associated with cough?
A. COPD
B. Asthma
C. Allergicrhinitis
D. A&C
E. All
E
The following route of drug administration is/are used in respiratory diseases.
A. Oral
B. Parenteral
C. Inhaled
D. Topical
E. All
E
Nasal sprays or inhalers are preferred for some respiratory conditions with the following benefits.
A. Targettheaffectedtissue
B.Minimizes systemic adverse effects
C. Both
D. Neither
C
Classification of bronchial asthma which shows more than once daily bronchoconstrictive episodes.
A. Mildintermittent
B. Mildpersistent
C. Moderatepersistent
D. Severepersistent
E. None
D
Classification of bronchial asthma that needs a low dose of inhaler corticosteroid only for long term control.
A. Mild intermittent
B. Mild persistent
C. Moderate persistent
D. Severe persistent
E. None
B
Medication used for long term control in severe persistent asthma
A. HighdoseICS+longactingbeta2
agonist
B. MediumdoseICS+LABA
C. LowdoseICS
D. Nodailymedication
E. None
A
Which of the following is/are causes of bronchoconstriction in bronchial asthma?
A. Inflamedbronchialwall
B.Contractionofbronchialsmoothmuscles
C. Increasesecretionofmucus
D. A&C
E. All
E
The following can trigger asthma attacks.
A. Allergens
B. Exercise C. Stress D. A&C E. All
E
Which of the following cells is associated with
the pathophysiology in bronchial asthma.
A. RBC
B. Mast cells
C. WBC
D. A&C
E. All
B
Goals of asthma therapy:
A. Decrease intensity & frequency
B. Preventing future
C. Minimize limitation in activity
D. A&C
E. All
E
Quick relief of asthma symptoms
A. ICS
B. Shortactingbeta2agonist
C. Longactingbeta2agonist
D. A&C
E. All
B
The drug of choice for long term control with persistent asthma
A. SABA
B. LABA
C. ICS
D. All
E. None
C
Short acting beta 2 agonist can be used as
monotherapy in the following
A. Mildintermittentasthma
B. Moderatepersistentasthma
C. Exercise-induced bronchospasm
D. A&C
E. All
E